Elicio Therapeutics, Inc. (ELTX) is a clinical-stage biopharmaceutical company. The provided filing section is a Power of Attorney and signature page from a 10-K annual report, and does not contain detailed business description information. Based on available data, the company is led by CEO Robert Connelly and Chief Strategy and Financial Officer Preetam Shah, Ph.D., M.B.A., and filed its annual report on March 12, 2026.
expected 2026-12-14
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-12 | 2025-12-31 | 0001601485-26-000027 | EDGAR | 111K words |
| 2025-03-31 | 2024-12-31 | 0001601485-25-000049 | EDGAR | 101K words |
| 2024-03-29 | 2023-12-31 | 0001601485-24-000023 | EDGAR | 97K words |
| 2023-03-17 | 2022-12-31 | 0001601485-23-000011 | EDGAR | 64K words |
| 2022-03-30 | 2021-12-31 | 0001601485-22-000022 | EDGAR | — |
| 2021-03-30 | 2020-12-31 | 0001601485-21-000007 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-13 | 2026-06-30 | 0001601485-26-000056 | EDGAR | 24K words |
| 2025-11-13 | 2025-09-30 | 0001601485-25-000124 | EDGAR | 20K words |
| 2025-08-07 | 2025-06-30 | 0001601485-25-000111 | EDGAR | 20K words |
| 2025-05-13 | 2025-03-31 | 0001601485-25-000074 | EDGAR | 18K words |
| 2024-11-13 | 2024-09-30 | 0001601485-24-000075 | EDGAR | 25K words |
| 2024-08-13 | 2024-06-30 | 0001601485-24-000045 | EDGAR | 24K words |
| 2024-05-15 | 2024-03-31 | 0001601485-24-000033 | EDGAR | 20K words |
| 2023-11-13 | 2023-09-30 | 0001601485-23-000082 | EDGAR | 26K words |
| 2023-08-14 | 2023-06-30 | 0001601485-23-000052 | EDGAR | 25K words |
| 2023-05-10 | 2023-03-31 | 0001601485-23-000035 | EDGAR | 22K words |
| 2022-11-14 | 2022-09-30 | 0001601485-22-000070 | EDGAR | 44K words |
| 2022-08-15 | 2022-06-30 | 0001601485-22-000066 | EDGAR | 27K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-14 | 0001601485-26-000058 | EDGAR | 1K words |
| 2026-08-13 | 0001601485-26-000055 | EDGAR | 1K words |
| 2026-03-16 | 0001601485-26-000032 | EDGAR | 24K words |
| 2026-03-12 | 0001601485-26-000026 | EDGAR | 1K words |
| 2025-11-13 | 0001601485-25-000123 | EDGAR | 1K words |
| 2025-09-17 | 0001193125-25-205522 | EDGAR | 2K words |
| 2025-08-12 | 0001601485-25-000114 | EDGAR | 0K words |
| 2025-08-07 | 0001601485-25-000108 | EDGAR | 1K words |
| 2025-08-05 | 0001601485-25-000099 | EDGAR | 1K words |
| 2025-06-04 | 0001601485-25-000096 | EDGAR | 15K words |
122 total filings indexed. 94 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001601485 |
| Ticker | ELTX |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.elicio.com |
| Listed | 2023-06-02 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/ELTX (~200 tokens, structured JSON with cryptographic provenance)